Olmesartan Medoxomil and Rosuvastatin Tablets 20/20 mg

Adult dose

Olmesartan Medoxomil: The recommended initial dose is 10 mg once daily, administered irrespective of meals. If blood pressure is not adequately controlled, increase to 20 mg once daily. The maximum allowable dose is 40 mg per day. Can be used in combination with diuretics such as hydrochlorothiazide. Rosuvastatin: The initial dose is 5 mg once daily, and the maintenance dose is 10 mg once daily. If needed.

Child dose

The safety and efficacy in children under 18 years have not been established.

This medication may cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be administered to certain patients, including those allergic to this drug or its components, pregnant women, nursing women, patients with severely impaired renal function, patients with severe liver impairment, and patients with bile duct obstruction. Patients with decreased blood volume or low salt, patients with impaired renal function, and patients at risk of hyperkalemia should be especially cautious when taking this medication, and blood pressure, renal function, and potassium levels should be monitored regularly during treatment. This medication can affect the liver and muscles, so if symptoms of liver dysfunction, muscle pain, or muscle weakness occur, medical personnel should be informed immediately. This medication may interact with other drugs, so caution is needed especially when taken with potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, certain antibiotics, and other lipid-lowering medications. Pregnant and nursing women are advised not to use this medication, and women of childbearing potential should use appropriate contraceptive methods. The safety and efficacy of this drug in children and adolescents under 18 years have not been adequately established. In elderly patients, dose adjustments may be necessary, and overdose may present symptoms such as hypotension and palpitations, requiring immediate medical assistance. This medication should be kept out of reach of children and should not be transferred to another container. Dizziness or drowsiness may occur during treatment, so it is safer to avoid driving or operating hazardous machinery.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, difficulty breathing, asthma attack, respiratory abnormalities with cough + fever, jaundice (yellowing of skin or eyes), profound lethargy, sudden and very severe headache, lightning headache, seizures, loss of consciousness, visual disturbances, paralysis, urination

Mild side effects

• Headache
• dizziness
• decreased sensation
• drowsiness
• gastroesophageal reflux disease
• constipation
• cavities
• dyspepsia
• gastric ulcer
• gastritis

This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to ensure the medication's effectiveness.

Appearance

White or yellowish round film-coated tablets

Package unit

30 tablets/PTP [30 tablets (10 tablets/Alu-Alu) x 3]